Cencora to Acquire Majority Stake in OneOncology from TPG

CareMetx Acquires Cencora’s U.S. Hub Patient Services and Free Goods Pharmacy Operations

April 27, 2026

Healthcare Services

CareMetx acquired Cencora’s U.S. hub consulting services operations previously conducted under the Lash Group, including TheraCom free goods pharmacy operations. The deal expands CareMetx’s end-to-end patient access platform by adding full-service hub operations, patient access staffing infrastructure, and free goods pharmacy fulfillment.

Cencora to Acquire EyeSouth Partners' Retina Business for $1.1 Billion

March 24, 2026

Healthcare Services

Cencora has signed a definitive agreement to acquire the retina business of EyeSouth Partners for $1.1 billion. The affiliated retina physicians will join Cencora’s Retina Consultants of America (RCA) management services platform, strengthening Cencora’s specialty ophthalmology services footprint.

Cencora and Covetrus to Merge with MWI Animal Health

February 18, 2026

Healthcare Services

Cencora and Covetrus have entered into a definitive agreement to merge Covetrus with MWI Animal Health (MWI), creating a comprehensive animal health platform. The transaction values MWI at an enterprise value of $3.5 billion, with Cencora receiving cash and preferred equity proceeds while retaining a non-controlling 34.3% common equity stake in the combined company.

Cencora To Acquire Retina Consultants of America in $4.6 Billion Deal

November 10, 2024

Healthcare Services

Cencora entered into a definitive agreement to acquire Retina Consultants of America (RCA), a leading retina specialist management services organization (MSO), from Webster Equity Partners. The deal values RCA at approximately $4.6 billion in cash, with additional potential contingent consideration of up to $500 million, and is expected to close subject to customary regulatory approvals.

TPG and AmerisourceBergen Acquire OneOncology from General Atlantic

April 20, 2023

Healthcare Services

TPG has agreed to acquire a majority interest in OneOncology and AmerisourceBergen will take a roughly 35% minority stake for approximately $685 million, valuing OneOncology at $2.1 billion. OneOncology's affiliated practices, physicians, and management will retain minority ownership as the parties form a new joint venture; the network includes over 900 affiliated providers across 14 states and the deal is expected to close by the end of September 2023.

TPG Completes Majority Investment in iNova Pharmaceuticals

October 31, 2022

Pharmaceuticals

TPG (through its Asia platform) completed a majority investment in iNova Pharmaceuticals, a multinational consumer health and pharmaceutical company, with existing investor Pacific Equity Partners re-investing as a minority co-investor. The deal will support iNova's regional expansion and growth strategy across Southeast and North Asia, and fund channel expansion, product-in-fill and technology investments.